Developer docs
API playgroundTry for free, no card

Search company profiles

Observia

Full company profile

uuid000bkas

Namestring
Observia
Legal namestring
Observia SAS
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Observia is a French digital health company founded in 2011 and headquartered in Puteaux (La Défense), France. It develops patient engagement and behavioral diagnostic solutions sold primarily to pharmaceutical manufacturers (including Bayer, Novartis, and Sanofi), healthcare providers, insurers, payers, and pharmacy networks. The company reports a footprint of 100+ active clients, 80+ e-health solutions, 25+ countries, and 120 health specialties, with 50,000+ patients assessed by SPUR and 30,000 active patients across its platforms. The company holds 101–250 employees and operates under GDPR and HIPAA compliance frameworks.

The product portfolio rests on three core technologies: SPUR™, a behavioral diagnostic tool that measures drivers of patient non-adherence on a 0–100 scoring framework and is documented across 27 therapeutic areas and 7+ peer-reviewed publications; OPC™ (Observia Patient Cloud), the platform hosting 80+ e-health modules covering patient education, remote monitoring, and tele-consultation; and d.tells™, an AI-driven personalization and recommendation engine built on top of SPUR data. Adjacent offerings include SPUR4Care (prescriber-focused variant) and co-developed branded engagement programs such as "solike" with Bayer Germany.

The business model is B2B enterprise SaaS, monetized through licensed deployments of SPUR, OPC program subscriptions, and joint patient engagement programs co-built with pharma brand teams. Distribution is reinforced by a long-standing licensing arrangement with Mapi Research Trust and more recent clinical trial partnerships with Clinical Ink and Sciensus, which embed the platform into research and care-delivery workflows rather than competing as a standalone tool. The company has extended its physical footprint with a Shanghai subsidiary and Germany team established in 2018.

Short descriptiontext

Observia is a French digital health company that builds patient engagement and behavioral diagnostic solutions — most notably the SPUR™ adherence tool and OPC™ platform — for pharmaceutical companies, healthcare providers, insurers, and clinical trial sponsors across 25+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPuteaux, France
HQ citystring
Puteaux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient engagement software, behavioral diagnostic tools, medication adherence solutions, digital health platforms, healthcare consulting services
Industry3 codes
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Offices of Physicians6211
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Health / Patient Engagement Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Observia provides its SPUR tool and OPC platform to pharmaceutical companies, healthcare providers, and CROs through enterprise agreements. The company offers configurable solutions that pharmaceutical companies deploy for patient support programs, clinical trials, and market research.

observia-group.com
2Consulting Services
TypeProfessional Services
Description

Over 100 consulting projects including patient journey mapping, behavioral science consulting, and implementation support for pharma companies seeking to improve patient engagement and adherence.

observia-group.com
3Platform Licensing
TypeLicensing Royalties
Description

Licensing of OPC platform modules and d.tells personalization engine to pharmaceutical companies and healthcare organizations for building customized patient engagement solutions.

observia-group.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise B2B contracts for pharmaceutical companies and healthcare organizations
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom enterprise agreements based on scope of deployment, therapeutic areas covered, and feature configuration requirements.

observia-group.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1SPUR™
Description

First verified behavioral diagnostic tool that measures medication non-adherence risk and identifies behavioral drivers across 4 dimensions (Social, Psychological, Usage, Rational) with 13 underlying factors.

observia-group.com
+8 more records
Core offering1 text field

Observia develops and licenses a behavioral-science-driven patient engagement software suite for healthcare organizations. Its core offerings are SPUR™, a validated behavioral diagnostic tool that scores non-adherence risk and profiles patients across four dimensions and 13 drivers; OPC™ (Observia Patient Cloud), a modular platform with 40+ configurable e-health modules for omnichannel patient support programs; and d.tells™, an AI personalization engine that maps patient behavioral profiles to optimal content, channels, and timing. The company complements this software with professional consulting services for patient journey mapping, behavioral science integration, and program implementation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Treatment adherence in Type 2 diabetes patients increased from 60% to 87% over 6 months
+5 more records
Product overview1 text field

Observia offers a modular e-health platform architecture centered around three core products: OPC (Observia Patient Cloud) as the foundational digital platform with over 40 configurable modules; SPUR, a validated behavioral diagnostic tool generating 18 data points per patient including non-adherence risk scores and behavioral profiles across 4 dimensions and 13 drivers; and d.tells, an AI-powered personalization engine that matches patient behavioral data to optimal engagement configurations. The portfolio includes specialized solutions for pharmaceutical companies, healthcare professionals (SPUR4Care), pharmacists, and patients, with products addressing specific conditions such as multiple myeloma (HéMaVie), diabetes (Inodiab), and patient-caregiver matching (solike). The platform supports omnichannel delivery via email, SMS, chatbots, apps, and call centers, and is grounded in behavioral science methodologies.

Product and service13 records
1SPUR™
CategoryBehavioral diagnostic software
Description

Validated behavioral diagnostic tool that generates 18 data points per patient including a non-adherence risk score on a 0-100 scale, a holistic behavioral profile across four dimensions (Social, Psychological, Usage, Rational), and 13 behavioral drivers. Used by 50,000+ patients across 27 therapeutic areas with a 90% completion rate and under 3 minutes to complete.

2OPC™ (Observia Patient Cloud)
CategoryModular e-health platform
Description

Adaptable digital platform with a library of over 40 configurable e-health features for creating patient services and support programs. Supports multiple user types, devices, and channels (email, SMS, chatbots, apps, call centers), GDPR- and HIPAA-compliant, deployable across 13+ countries in 12+ languages.

3d.tells™
CategoryAI personalization engine
Description

AI-powered personalization engine that creates personalized engagement plans by matching SPUR-derived patient behavioral profiles with optimal content, channels, timing, frequency, and tone. Automates selection and distribution of OPC platform features across multiple delivery channels.

4SPUR4Care
CategoryBehavioral diagnostic software (HCP edition)
Description

Version of SPUR designed specifically for healthcare professionals (prescribers) to collect objective behavioral data during patient consultations to support clinical practice.

5Pharmacist Platform
CategoryPharmacist digital engagement platform
Description

Platform dedicated to supporting community pharmacists in France with pharmaceutical interviews and shared medication reviews for chronic patients. Used by 4,000+ registered pharmacists with 12,000+ pharmaceutical interviews completed since 2013.

6solike
CategoryPatient-caregiver matching platform
Description

First-of-its-kind patient and caregiver matching platform launched in partnership with Bayer Germany in 2023, designed to connect patients with their caregivers.

7My VKA Notebook
CategoryMobile health application
Description

Mobile application co-created with University of Angers for patients on anti-vitamin K anticoagulants, enabling monitoring of test results (INR), treatment reminders, appointment logging, and medication dosing information. Awarded Prix Galien 2017.

8L'Arbre Conseils® Mal de Tête
CategoryPharmacist decision-support tool
Description

Digital support tool co-created with Sanofi for pharmacists providing counseling advice to patients suffering from headaches at the pharmacy counter. Awarded Prix Galien 2023.

9HéMaVie™
CategoryPatient support program
Description

Innovative digital support solution for patients suffering from multiple myeloma, providing comprehensive patient engagement features through the OPC platform.

10Inodiab
CategoryPatient adherence program
Description

SMS-based personalized program for improving Type 2 diabetes patient adherence through tailored SMS interventions delivered via community pharmacists.

11CaliPso
CategoryPatient support program
Description

Digital solution supporting daily management of psoriasis by patients, leveraging OPC modular features for ongoing engagement.

12OSyS
CategoryPharmacy triage platform
Description

First digital platform for first-recourse orientation at the pharmacy, helping pharmacists triage and direct patients to appropriate care.

13Observia Consulting Services
CategoryHealthcare consulting services
Description

Professional consulting services including patient journey mapping, behavioral science consulting, and implementation support for pharmaceutical and healthcare clients seeking to improve patient engagement and adherence. Over 100 consulting projects delivered.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborated with Kingston University to develop SPUR 6/24 patient-reported outcome tool. Joint research analyzed data from over 1,800 patients across three countries to identify psychological and social factors influencing medication non-adherence in chronic conditions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to expand patient engagement solutions using SPUR behavioral diagnostic tool in clinical trials. Combines Clinical Ink's eClinical platform with Observia's behavioral insights.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to strengthen clinical trial offerings by integrating behavioral science into patient solutions through Sciensus's existing patient support programs.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partnership for SPUR tool among research community. Mapi Research Trust distributes SPUR to academic and clinical researchers worldwide.

5Prevention Journeys
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to improve dementia prevention through behavioral science integration and patient engagement programs.

observia-group.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched solike platform in Germany - a patient-caregiver matching service. Also partnered on menopause patient journey studies using SPUR and photo-elicitation methodologies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-created My VKA Notebook app (Prix Galien 2017) for patients on anti-vitamin K medication, and L'Arbre Conseils Mal de Tête solution (Prix Galien 2023) for pharmacist counseling.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eurostars-funded agentic AI project to address patient adherence. Joint development of AI-powered patient engagement solutions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Integration of behavioral science into UNFPA programs with Kevin Dolgin and Anthony Daly, exploring behavioral science applications in public health contexts.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Prescription digital therapeutics company combining behavioral science with software for chronic and mental health conditions. Comparable in its marriage of validated behavioral models and engagement platforms.

TypeDirect peer
Description

Patient engagement and chronic care management platform with omnichannel outreach (SMS, email, app). Comparable architecture to OPC, though more provider-centric than pharma-centric.

TypeDirect peer
Description

Pharma-facing digital health company offering patient engagement and adherence solutions (e.g., Insulia), with a comparable therapeutic-area focus and pharma co-development model that closely overlaps with Observia's SPUR + OPC + d.tells stack.

TypeDirect peer
Description

Medication adherence and patient engagement platform with a personalized digital companion model. Directly comparable to Observia's OPC platform in the chronic-disease adherence category.

TypeDirect peer
Description

Pharma- and medtech-focused digital patient engagement and adherence platform with multi-year enterprise contracts. Highly comparable business model and customer base to Observia.

TypeDirect peer
Description

Digital health company focused on chronic disease management with AI-driven personalization (similar to d.tells) and pharma/payer enterprise contracts, overlapping with Observia's therapeutic-area coverage.

TypeEmerging player
Description

Digital therapeutics for musculoskeletal and chronic pain, leveraging behavioral science and personalized engagement. Comparable to Observia's therapeutic-area + behavioral science orientation but more consumer-payer channel.

8Biofourmis
TypeBroad incumbent
Description

Larger virtual care and remote patient monitoring platform with pharma partnerships and AI-driven personalization, overlapping with Observia's chronic-disease patient engagement ambitions.

TypeBroad incumbent
Description

Digital health engagement platform combining behavioral science with enterprise pharma/health plan distribution, conceptually aligned with Observia's behavioral-engagement-for-pharma model at a larger scale.

TypeDirect peer
Description

Respiratory and chronic-disease adherence technology company with validated clinical evidence. Comparable in focusing on adherence outcomes and pharma partnerships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Observia

Digital Health / Patient Engagement Softwareobservia-group.com

Observia is a French digital health company that builds patient engagement and behavioral diagnostic solutions — most notably the SPUR™ adherence tool and OPC™ platform — for pharmaceutical companies, healthcare providers, insurers, and clinical trial sponsors across 25+ countries.

What Observia does

Observia is a French digital health company founded in 2011 and headquartered in Puteaux (La Défense), France. It develops patient engagement and behavioral diagnostic solutions sold primarily to pharmaceutical manufacturers (including Bayer, Novartis, and Sanofi), healthcare providers, insurers, payers, and pharmacy networks. The company reports a footprint of 100+ active clients, 80+ e-health solutions, 25+ countries, and 120 health specialties, with 50,000+ patients assessed by SPUR and 30,000 active patients across its platforms. The company holds 101–250 employees and operates under GDPR and HIPAA compliance frameworks.

The product portfolio rests on three core technologies: SPUR™, a behavioral diagnostic tool that measures drivers of patient non-adherence on a 0–100 scoring framework and is documented across 27 therapeutic areas and 7+ peer-reviewed publications; OPC™ (Observia Patient Cloud), the platform hosting 80+ e-health modules covering patient education, remote monitoring, and tele-consultation; and d.tells™, an AI-driven personalization and recommendation engine built on top of SPUR data. Adjacent offerings include SPUR4Care (prescriber-focused variant) and co-developed branded engagement programs such as "solike" with Bayer Germany.

The business model is B2B enterprise SaaS, monetized through licensed deployments of SPUR, OPC program subscriptions, and joint patient engagement programs co-built with pharma brand teams. Distribution is reinforced by a long-standing licensing arrangement with Mapi Research Trust and more recent clinical trial partnerships with Clinical Ink and Sciensus, which embed the platform into research and care-delivery workflows rather than competing as a standalone tool. The company has extended its physical footprint with a Shanghai subsidiary and Germany team established in 2018.

Observia firmographics

Firmographics
Name
Observia
Legal name
Observia SAS
Website
https://observia-group.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Observia is a French digital health company that builds patient engagement and behavioral diagnostic solutions — most notably the SPUR™ adherence tool and OPC™ platform — for pharmaceutical companies, healthcare providers, insurers, and clinical trial sponsors across 25+ countries.
Ownership category
akta.pro rank

Observia industry classification

Industry
Product category
Digital Health / Patient Engagement Software
NAICS
Custom Computer Programming Services (541511), Offices of Physicians (6211)
SIC
Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Patient engagement software
  • Behavioral diagnostic tools
  • Medication adherence solutions
  • Digital health platforms
  • Healthcare consulting services

Where Observia is headquartered

Location

Headquarters

HQ city
Puteaux
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Observia business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Enterprise Software Licenses and Subscriptions: Observia provides its SPUR tool and OPC platform to pharmaceutical companies, healthcare providers, and CROs through enterprise agreements. The company offers configurable solutions that pharmaceutical companies deploy for patient support programs, clinical trials, and market research.
  2. Consulting Services: Over 100 consulting projects including patient journey mapping, behavioral science consulting, and implementation support for pharma companies seeking to improve patient engagement and adherence.
  3. Platform Licensing: Licensing of OPC platform modules and d.tells personalization engine to pharmaceutical companies and healthcare organizations for building customized patient engagement solutions.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise B2B contracts for pharmaceutical companies and healthcare organizations

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Observia product offering

Product offering

Core offering

Observia develops and licenses a behavioral-science-driven patient engagement software suite for healthcare organizations. Its core offerings are SPUR™, a validated behavioral diagnostic tool that scores non-adherence risk and profiles patients across four dimensions and 13 drivers; OPC™ (Observia Patient Cloud), a modular platform with 40+ configurable e-health modules for omnichannel patient support programs; and d.tells™, an AI personalization engine that maps patient behavioral profiles to optimal content, channels, and timing. The company complements this software with professional consulting services for patient journey mapping, behavioral science integration, and program implementation.

Product overview

Observia offers a modular e-health platform architecture centered around three core products: OPC (Observia Patient Cloud) as the foundational digital platform with over 40 configurable modules; SPUR, a validated behavioral diagnostic tool generating 18 data points per patient including non-adherence risk scores and behavioral profiles across 4 dimensions and 13 drivers; and d.tells, an AI-powered personalization engine that matches patient behavioral data to optimal engagement configurations. The portfolio includes specialized solutions for pharmaceutical companies, healthcare professionals (SPUR4Care), pharmacists, and patients, with products addressing specific conditions such as multiple myeloma (HéMaVie), diabetes (Inodiab), and patient-caregiver matching (solike). The platform supports omnichannel delivery via email, SMS, chatbots, apps, and call centers, and is grounded in behavioral science methodologies.

Differentiator

Problem solved

Functional benefit

Brands

  • SPUR™: First verified behavioral diagnostic tool that measures medication non-adherence risk and identifies behavioral drivers across 4 dimensions (Social, Psychological, Usage, Rational) with 13 underlying factors.
  • OPC™ (Observia Patient Cloud)
  • d.tells™
  • My VKA Notebook
  • solike
  • HéMaVie™
  • CaliPso
  • L'Arbre Conseil®
  • OSyS

Products and services

  • SPUR™ Validated behavioral diagnostic tool that generates 18 data points per patient including a non-adherence risk score on a 0-100 scale, a holistic behavioral profile across four dimensions (Social, Psychological, Usage, Rational), and 13 behavioral drivers. Used by 50,000+ patients across 27 therapeutic areas with a 90% completion rate and under 3 minutes to complete.
  • OPC™ (Observia Patient Cloud) Adaptable digital platform with a library of over 40 configurable e-health features for creating patient services and support programs. Supports multiple user types, devices, and channels (email, SMS, chatbots, apps, call centers), GDPR- and HIPAA-compliant, deployable across 13+ countries in 12+ languages.
  • d.tells™ AI-powered personalization engine that creates personalized engagement plans by matching SPUR-derived patient behavioral profiles with optimal content, channels, timing, frequency, and tone. Automates selection and distribution of OPC platform features across multiple delivery channels.
  • SPUR4Care Version of SPUR designed specifically for healthcare professionals (prescribers) to collect objective behavioral data during patient consultations to support clinical practice.
  • Pharmacist Platform Platform dedicated to supporting community pharmacists in France with pharmaceutical interviews and shared medication reviews for chronic patients. Used by 4,000+ registered pharmacists with 12,000+ pharmaceutical interviews completed since 2013.
  • solike First-of-its-kind patient and caregiver matching platform launched in partnership with Bayer Germany in 2023, designed to connect patients with their caregivers.
  • My VKA Notebook Mobile application co-created with University of Angers for patients on anti-vitamin K anticoagulants, enabling monitoring of test results (INR), treatment reminders, appointment logging, and medication dosing information. Awarded Prix Galien 2017.
  • L'Arbre Conseils® Mal de Tête Digital support tool co-created with Sanofi for pharmacists providing counseling advice to patients suffering from headaches at the pharmacy counter. Awarded Prix Galien 2023.
  • HéMaVie™ Innovative digital support solution for patients suffering from multiple myeloma, providing comprehensive patient engagement features through the OPC platform.
  • Inodiab SMS-based personalized program for improving Type 2 diabetes patient adherence through tailored SMS interventions delivered via community pharmacists.
  • CaliPso Digital solution supporting daily management of psoriasis by patients, leveraging OPC modular features for ongoing engagement.
  • OSyS First digital platform for first-recourse orientation at the pharmacy, helping pharmacists triage and direct patients to appropriate care.
  • Observia Consulting Services Professional consulting services including patient journey mapping, behavioral science consulting, and implementation support for pharmaceutical and healthcare clients seeking to improve patient engagement and adherence. Over 100 consulting projects delivered.

Quantifiable outcome

  • Treatment adherence in Type 2 diabetes patients increased from 60% to 87% over 6 months
  • +5 more outcomes

Companies that use Observia

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Observia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Observia partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Kingston UniversitycoreStrategic or Co-development PartnerCollaborated with Kingston University to develop SPUR 6/24 patient-reported outcome tool. Joint research analyzed data from over 1,800 patients across three countries to identify psychological and social factors influencing medication non-adherence in chronic conditions.
  • Clinical InkcoreStrategic or Co-development PartnerStrategic partnership to expand patient engagement solutions using SPUR behavioral diagnostic tool in clinical trials. Combines Clinical Ink's eClinical platform with Observia's behavioral insights.
  • SciensuscoreStrategic or Co-development PartnerStrategic partnership to strengthen clinical trial offerings by integrating behavioral science into patient solutions through Sciensus's existing patient support programs.
  • Mapi Research TrustcoreChannel Partner/ Reseller/ DistributorDistribution partnership for SPUR tool among research community. Mapi Research Trust distributes SPUR to academic and clinical researchers worldwide.
  • Prevention JourneysminorStrategic or Co-development PartnerPartnership to improve dementia prevention through behavioral science integration and patient engagement programs.
  • BayercoreStrategic or Co-development PartnerLaunched solike platform in Germany - a patient-caregiver matching service. Also partnered on menopause patient journey studies using SPUR and photo-elicitation methodologies.
  • SanoficoreStrategic or Co-development PartnerCo-created My VKA Notebook app (Prix Galien 2017) for patients on anti-vitamin K medication, and L'Arbre Conseils Mal de Tête solution (Prix Galien 2023) for pharmacist counseling.
  • XPERTymecoreStrategic or Co-development PartnerEurostars-funded agentic AI project to address patient adherence. Joint development of AI-powered patient engagement solutions.
  • UNFPAminorStrategic or Co-development PartnerIntegration of behavioral science into UNFPA programs with Kevin Dolgin and Anthony Daly, exploring behavioral science applications in public health contexts.

Scale indicators16 records

Recent moves10 records

Expansion highlights6 records

Observia competitors and assessment

Company assessment

Direct peers

  • Click Therapeutics: Prescription digital therapeutics company combining behavioral science with software for chronic and mental health conditions. Comparable in its marriage of validated behavioral models and engagement platforms.
  • Optimize Health: Patient engagement and chronic care management platform with omnichannel outreach (SMS, email, app). Comparable architecture to OPC, though more provider-centric than pharma-centric.
  • Aptar Digital Health (formerly Voluntis): Pharma-facing digital health company offering patient engagement and adherence solutions (e.g., Insulia), with a comparable therapeutic-area focus and pharma co-development model that closely overlaps with Observia's SPUR + OPC + d.tells stack.
  • Medisafe: Medication adherence and patient engagement platform with a personalized digital companion model. Directly comparable to Observia's OPC platform in the chronic-disease adherence category.
  • S3 Connected Health: Pharma- and medtech-focused digital patient engagement and adherence platform with multi-year enterprise contracts. Highly comparable business model and customer base to Observia.
  • Welldoc: Digital health company focused on chronic disease management with AI-driven personalization (similar to d.tells) and pharma/payer enterprise contracts, overlapping with Observia's therapeutic-area coverage.
  • Adherium: Respiratory and chronic-disease adherence technology company with validated clinical evidence. Comparable in focusing on adherence outcomes and pharma partnerships.

Emerging players

  • Kaia Health: Digital therapeutics for musculoskeletal and chronic pain, leveraging behavioral science and personalized engagement. Comparable to Observia's therapeutic-area + behavioral science orientation but more consumer-payer channel.

Broad incumbents

  • Biofourmis: Larger virtual care and remote patient monitoring platform with pharma partnerships and AI-driven personalization, overlapping with Observia's chronic-disease patient engagement ambitions.
  • Twill (formerly Happify Health): Digital health engagement platform combining behavioral science with enterprise pharma/health plan distribution, conceptually aligned with Observia's behavioral-engagement-for-pharma model at a larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Observia social profiles

Digital presence

Observia compliance and trust

Trust signal

Compliance2 records

Observia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Observia leadership team

Management profile

Number of profiles

Profiles5 records

Observia subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Observia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Observia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Observia

What does Observia do?

Observia develops and licenses a behavioral-science-driven patient engagement software suite for healthcare organizations. Its core offerings are SPUR™, a validated behavioral diagnostic tool that scores non-adherence risk and profiles patients across four dimensions and 13 drivers; OPC™ (Observia Patient Cloud), a modular platform with 40+ configurable e-health modules for omnichannel patient support programs; and d.tells™, an AI personalization engine that maps patient behavioral profiles to optimal content, channels, and timing. The company complements this software with professional consulting services for patient journey mapping, behavioral science integration, and program implementation.

Is Observia a public or private company?

Observia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Observia founded?

Observia was founded in 2011. It employs 11 to 50 people.

Where is Observia based?

Observia is headquartered in Puteaux, France, in the Europe region.

How does Observia make money?

Three revenue lines are on record. Enterprise Software Licenses and Subscriptions are the primary driver. The others are consulting Services and platform Licensing.

Who are Observia's main competitors?

Direct peers on record are Click Therapeutics, Optimize Health, Aptar Digital Health (formerly Voluntis), Medisafe, S3 Connected Health, Welldoc and Adherium. Kaia Health is listed as an emerging player. Broad incumbents are Biofourmis and Twill (formerly Happify Health).

Does Observia have an API?

No public API is recorded for Observia.

What industry is Observia in?

Observia's product category is Digital Health / Patient Engagement Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales